189 related articles for article (PubMed ID: 36265125)
1. Effect of Comorbidities on the Infection Rate and Severity of COVID-19: Nationwide Cohort Study With Propensity Score Matching.
Kim J; Park SH; Kim JM
JMIR Public Health Surveill; 2022 Nov; 8(11):e35025. PubMed ID: 36265125
[TBL] [Abstract][Full Text] [Related]
2. Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study.
Kim B; Jung JH; Han K; Kang S; Lee E; Chung H; Kim SG; Cho SJ
J Korean Med Sci; 2023 Apr; 38(13):e99. PubMed ID: 37012686
[TBL] [Abstract][Full Text] [Related]
3. Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study.
Lee SW; Yang JM; Moon SY; Yoo IK; Ha EK; Kim SY; Park UM; Choi S; Lee SH; Ahn YM; Kim JM; Koh HY; Yon DK
Lancet Psychiatry; 2020 Dec; 7(12):1025-1031. PubMed ID: 32950066
[TBL] [Abstract][Full Text] [Related]
4. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
Ge E; Li Y; Wu S; Candido E; Wei X
PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
[TBL] [Abstract][Full Text] [Related]
5. Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study.
Yang JM; Koh HY; Moon SY; Yoo IK; Ha EK; You S; Kim SY; Yon DK; Lee SW
J Allergy Clin Immunol; 2020 Oct; 146(4):790-798. PubMed ID: 32810517
[TBL] [Abstract][Full Text] [Related]
6. Pregnant women with SARS-CoV-2 infection are at higher risk of death and pneumonia: propensity score matched analysis of a nationwide prospective cohort (COV19Mx).
Martinez-Portilla RJ; Sotiriadis A; Chatzakis C; Torres-Torres J; Espino Y Sosa S; Sandoval-Mandujano K; Castro-Bernabe DA; Medina-Jimenez V; Monarrez-Martin JC; Figueras F; Poon LC
Ultrasound Obstet Gynecol; 2021 Feb; 57(2):224-231. PubMed ID: 33320401
[TBL] [Abstract][Full Text] [Related]
7. Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching.
Lee SW; Ha EK; Yeniova AÖ; Moon SY; Kim SY; Koh HY; Yang JM; Jeong SJ; Moon SJ; Cho JY; Yoo IK; Yon DK
Gut; 2021 Jan; 70(1):76-84. PubMed ID: 32732368
[TBL] [Abstract][Full Text] [Related]
8. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
[TBL] [Abstract][Full Text] [Related]
9. Patients with idiopathic pulmonary fibrosis have poor clinical outcomes with COVID-19 disease: a propensity matched multicentre research network analysis.
Naqvi SF; Lakhani DA; Sohail AH; Maurer J; Sofka S; Sarwari A; Hadi YB
BMJ Open Respir Res; 2021 Aug; 8(1):. PubMed ID: 34376400
[TBL] [Abstract][Full Text] [Related]
10. The anatomy of COVID-19 comorbidity networks among hospitalized Korean patients.
Shin EK; Choi HY; Hayes N
Epidemiol Health; 2021; 43():e2021035. PubMed ID: 33971700
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis.
Harrison SL; Fazio-Eynullayeva E; Lane DA; Underhill P; Lip GYH
PLoS Med; 2020 Sep; 17(9):e1003321. PubMed ID: 32911500
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the demographic characteristics and comorbidities of patients with COVID-19 who died in Spanish hospitals based on whether they were or were not admitted to an intensive care unit.
Miró Ò; Alquézar-Arbé A; Llorens P; Martín-Sánchez FJ; Jiménez S; Martín A; Burillo-Putze G; Jacob J; García-Lamberechts EJ; Piñera P; Del Castillo JG;
Med Intensiva (Engl Ed); 2021; 45(1):14-26. PubMed ID: 33158594
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study.
Jassat W; Cohen C; Tempia S; Masha M; Goldstein S; Kufa T; Murangandi P; Savulescu D; Walaza S; Bam JL; Davies MA; Prozesky HW; Naude J; Mnguni AT; Lawrence CA; Mathema HT; Zamparini J; Black J; Mehta R; Parker A; Chikobvu P; Dawood H; Muvhango N; Strydom R; Adelekan T; Mdlovu B; Moodley N; Namavhandu EL; Rheeder P; Venturas J; Magula N; Blumberg L;
Lancet HIV; 2021 Sep; 8(9):e554-e567. PubMed ID: 34363789
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death.
Phelps M; Christensen DM; Gerds T; Fosbøl E; Torp-Pedersen C; Schou M; Køber L; Kragholm K; Andersson C; Biering-Sørensen T; Christensen HC; Andersen MP; Gislason G
Eur Heart J Qual Care Clin Outcomes; 2021 Mar; 7(2):172-180. PubMed ID: 33107909
[TBL] [Abstract][Full Text] [Related]
16. Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico.
Martos-Benítez FD; Soler-Morejón CD; García-Del Barco D
Intern Emerg Med; 2021 Sep; 16(6):1507-1517. PubMed ID: 33411264
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study.
Shin YH; Shin JI; Moon SY; Jin HY; Kim SY; Yang JM; Cho SH; Kim S; Lee M; Park Y; Kim MS; Won HH; Hong SH; Kronbichler A; Koyanagi A; Jacob L; Smith L; Lee KH; Suh DI; Lee SW; Yon DK
Lancet Rheumatol; 2021 Oct; 3(10):e698-e706. PubMed ID: 34179832
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and impact of comorbidities on disease prognosis among patients with COVID-19 in Bangladesh: A nationwide study amid the second wave.
Sharif N; Opu RR; Ahmed SN; Sarkar MK; Jaheen R; Daullah MU; Khan S; Mubin M; Rahman H; Islam F; Haque N; Islam S; Khan FB; Haque N; Ayman U; Shohael AM; Dey SK; Talukder AA
Diabetes Metab Syndr; 2021; 15(4):102148. PubMed ID: 34186349
[TBL] [Abstract][Full Text] [Related]
19. Association of diabetes and outcomes in patients with COVID-19: Propensity score-matched analyses from a French retrospective cohort.
Sutter W; Duceau B; Vignac M; Bonnet G; Carlier A; Roussel R; Trimaille A; Pommier T; Guilleminot P; Sagnard A; Pastier J; Weizman O; Giordano G; Cellier J; Geneste L; Panagides V; Marsou W; Deney A; Karsenty C; Attou S; Delmotte T; Ribeyrolles S; Chemaly P; Gautier A; Fauvel C; Chaumont C; Mika D; Pezel T; Cohen A; Potier L;
Diabetes Metab; 2021 Jul; 47(4):101222. PubMed ID: 33388386
[TBL] [Abstract][Full Text] [Related]
20. The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea.
Kim MK; Jeon JH; Kim SW; Moon JS; Cho NH; Han E; You JH; Lee JY; Hyun M; Park JS; Kwon YS; Choi YK; Kwon KT; Lee SY; Jeon EJ; Kim JW; Hong HL; Kwon HH; Jung CY; Lee YY; Ha E; Chung SM; Hur J; Ahn JH; Kim NY; Kim SW; Chang HH; Lee YH; Lee J; Park KG; Kim HA; Lee JH
Diabetes Metab J; 2020 Aug; 44(4):602-613. PubMed ID: 32794386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]